These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 8625324)

  • 1. Multidrug resistance and malignancy in human osteosarcoma.
    Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
    Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
    Bodey B; Taylor CR; Siegel SE; Kaiser HE
    Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells.
    Scotlandi K; Manara MC; Serra M; Benini S; Maurici D; Caputo A; De Giovanni C; Lollini PL; Nanni P; Picci P; Campanacci M; Baldini N
    Oncogene; 1999 Jan; 18(3):739-46. PubMed ID: 9989824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
    Wang G; Rong J; Zhou Z; Duo J
    Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
    Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
    Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.
    Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N
    Oncol Rep; 2004 Jun; 11(6):1257-63. PubMed ID: 15138564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural features and P-glycoprotein immunolocalization in Saos-2/DX580 multidrug-resistant human osteosarcoma cells.
    Maraldi NM; Zini N; Sabatelli P; Valmori A; Scotlandi K; Serra M; Baldini N
    J Submicrosc Cytol Pathol; 1996 Jan; 28(1):93-100. PubMed ID: 8929631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model.
    Takeshita H; Kusuzaki K; Murata H; Suginoshita T; Hirata M; Hashiguchi S; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    Br J Cancer; 2000 Apr; 82(7):1327-31. PubMed ID: 10755409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the human multidrug resistance gene (MDR1) and prognostic correlation in human osteogenic sarcoma.
    Imanishi T; Abe Y; Suto R; Higaki S; Ueyama Y; Nakamura M; Tamaoki N; Fukuda H; Imai N
    Tokai J Exp Clin Med; 1994 Sep; 19(1-2):39-46. PubMed ID: 7660382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol.
    Serra M; Pasello M; Manara MC; Scotlandi K; Ferrari S; Bertoni F; Mercuri M; Alvegard TA; Picci P; Bacci G; Smeland S
    Int J Oncol; 2006 Dec; 29(6):1459-68. PubMed ID: 17088985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of multidrug-resistant human osteosarcoma cell lines.
    Serra M; Scotlandi K; Manara MC; Maurici D; Lollini PL; De Giovanni C; Toffoli G; Baldini N
    Anticancer Res; 1993; 13(2):323-9. PubMed ID: 8100126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy.
    Baldini N; Scotlandi K; Serra M; Picci P; Bacci G; Sottili S; Campanacci M
    J Orthop Res; 1999 Sep; 17(5):629-32. PubMed ID: 10569469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
    Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells.
    Manara MC; Serra M; Benini S; Picci P; Scotlandi K
    Int J Oncol; 2004 Feb; 24(2):365-72. PubMed ID: 14719113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mitomycin C and carboplatin pretreatment on multidrug resistance-associated P-glycoprotein expression and on subsequent suppression of tumor growth by doxorubicin and paclitaxel in human metastatic breast cancer xenografted nude mice.
    Ihnat MA; Nervi AM; Anthony SP; Kaltreider RC; Warren AJ; Pesce CA; Davis SA; Lariviere JP; Hamilton JW
    Oncol Res; 1999; 11(7):303-10. PubMed ID: 10757444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance-1 gene expression does not increase during tumor progression in the MGH-OGS murine osteosarcoma tumor model.
    Trammell RA; Johnson CB; Barker JR; Bell RS; Allan DG
    J Orthop Res; 2000 May; 18(3):449-55. PubMed ID: 10937633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.
    Chu F; Chou PM; Zheng X; Mirkin BL; Rebbaa A
    Cancer Res; 2005 Nov; 65(22):10183-7. PubMed ID: 16288004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.